Inventiv Health (VTIV) Inactive 10-Q2010 Q2 Quarterly report

Filed: 9 Aug 10, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: abetted, Additionally, advantage, agreeme, ahead, aided, al, alter, Amon, asse, ation, Beard, betwe, bidding, biologic, bundling, busi, busin, caption, captioned, Carter, Chancery, Citibank, civil, compensatory, compete, complementary, comprised, con, conflict, consensual, conservatism, consi, County, criminal, declaration, declare, dedicate, dedicated, disadvantage, disposition, distinct, duciary, duty, dynamic, ed, edge, ely, embarking, en, entit, equivalent, estimat, EUR, exclusively, expert, expose, faith, fi, fiduciary, flex, floating, fluct, fo, good, guarantee, harm, hesitation, HIPAA, HITECH, holder, honest, Human, id, indebte, indenture, indirect, ing, inhibit, injunction, innovative, insufficient, intermediate, Italy, ity, judgment, language, ly, maintenance, manner, matching, meant, merge, merit, nancial, noteholder, nt, occurrence, oldest, outlined, ovide, Palkon, platform, Portability, preliminary, premier, Prepa, prescribed, prevailing, promulgated, proxy, purpose, putative, Ramage, recipient, redeem, referenced, refinanced, refinancing, repay, repurchase, rescinding, rescissory, respectiv, restructure, retire, rger, se, Secretary, senior, ses, sider, simultaneously, Somerset, spanning, spectrum, stent, Substrathomme, suite, tendered, thereof, thinly, THL, transfer, ts, uate, unable, undercapitalized, Union, unique, unrelated, unwilling, vigorously, virtue, voluntarily, vulnerability, world

Removed: Columbia, commercialize, CSCP, demand, experienced, limitation, liquidated, marketable, portfolio, resulted, satisfaction, statute, trend, utilize

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

VTIV similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of inVentiv Health, Inc. (“the Company”) on Form 10-Q for the period ended June 30, 2010 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, R. Blane Walter, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and to the best of my knowledge and belief, that:

(1) The Report fully complies with the requirements of section 13 (a) or 15 (d) of the Securities Exchange Act of 1934 (16 U.S.C. 78m or 78o(d)); and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

	INVENTIV HEALTH, INC.

Date: August 9, 2010	By:	/s/ R. Blane Walter
		Name: R. Blane Walter
		Title: Chief Executive Officer

A signed original of this written statement required by Section 906 has been provided to inVentiv Health, Inc. and will be retained by inVentiv Health, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.